ArticleParasites & vectors2025
Determining mosquito age using surface-enhanced Raman spectroscopy and artificial neural networks: insights into the influence of origin and sex.
Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundMosquito-borne diseases, such as malaria, dengue, and Zika, continue to pose significant threats to global health, resulting in millions of cases and thousands of deaths each year. Notably, only older mosquitoes can transmit these diseases. Therefore, accurate age estimation of mosquitoes is vital for targeted interventions and risk assessments. However, traditional methods, such as tracheole morphology analysis, are labor-intensive and have limited scalability. Surface-enhanced Raman spectroscopy (SERS), when coupled with artificial neural networks (ANNs), offers a robust and flexible alternative, facilitating accurate and efficient mosquito age determination even in diverse and complex environmental conditions.
methodsWe analyzed 124 Aedes aegypti mosquitoes from California (CA) and Thailand (TH) using SERS, each generating 20 spectra. The ANNs utilized a multilayer perceptron with two hidden layers of 100 neurons and rectified linear unit (ReLU) activation. Classification tasks used cross-entropy loss; regression applied mean squared error. Models were trained with a 70-30 training-validation split and optimized using the Adam optimizer over 10,000 iterations. Performance metrics included accuracy, correlation coefficient (R), and root mean square error (RMSE). t-Distributed stochastic neighbor embedding (t-SNE) visualizations and confusion matrices offered additional model insights into effectiveness.
resultsThe ANN models demonstrated superior performance in differentiating mosquito age relative to non-ANN methods. For female CA mosquitoes, the models classified ages from day 1 to day 21 with 84% accuracy and predicted age with an R of 0.96 and RMSE of 2.18 days. Similarly, the models achieved 86% accuracy and an R-value of 0.95 for female TH mosquitoes. While mosquito origin and sex influenced performance, the combined model maintained robust results, achieving 80% accuracy and an R-value of 0.93. Implementing a voting mechanism across multiple spectra for each mosquito significantly improved accuracy, increasing classification performance from approximately 80% at the spectrum level to 100% at the mosquito level.
conclusionsThis study demonstrates the effectiveness of SERS combined with ANN for accurate age classification and prediction of Ae. aegypti mosquitoes. The models achieved high accuracy across diverse populations, with a voting mechanism enhancing classification to 100%. These findings highlight the potential of SERS-ANN as a reliable tool for vector control and disease surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.